IHH Healthcare

Results

IHH Healthcare’s 3QFY2024 patmi remains flat at RM534 mil

Earnings per share stood at 6.06 sen for the quarter, as compared to 6.04 sens in 3QFY2023.

Broker's Calls

DBS raises target price for Parkway Life REIT to $4.80

DBS estimates Parkway Life REIT's DPU can increase by 20% in FY2026
ParkwayLife REIT’s French acquisition to be more accretive than 1.6% to DPU - THE EDGE SINGAPORE

REITs

Parkway Life REIT’s French acquisition to be more than 1.6% accretive to DPU

Parkway Life REIT looks for closer collaboration with IHH, has a ROFR for Mount Elizabeth Novena, and manager explains rationale for French acquisition.

Property

IHH Healthcare to acquire Island Hospital in Penang for RM3.92 bil

Under the agreement, IHH Healthcare is set to acquire a 100% stake in Island Hospital.

Results

IHH Healthcare’s 2QFY2024 patmi more than doubles to RM623 mil

Earnings per share stood at 7.07 sen in 2QFY2024, up from a share of 3.43 sen in 2QFY2023.
IHH Healthcare appoints lawyer Tan Sri Dr Nik Norzrul Thani bin N Hassan Than as chairman - THE EDGE SINGAPORE

New appointments

IHH Healthcare appoints lawyer Tan Sri Dr Nik Norzrul Thani bin N Hassan Thani as chairman

Nik Nozrul succeeds Tan Sri Mohammed Azlan bin Hashim, who had elected to retire at the group’s annual general meeting in May.

Results

IHH Healthcare reports record quarterly revenue in 1QFY2024; patmi down 45% y-o-y on absence of one-off gains

In 1QFY2024, IHH recorded its highest ever quarterly revenue at RM6 billion, up 16% y-o-y.

Broker's Calls

DBS maintains 'buy' on IHH Healthcare even with softer industry-wide numbers

'This is an attractive level to ride on IHH Healthcare's medium-term growth trajectory'

Healthcare

Buyouts help Temasek-backed hospital firm Manipal vie for top India spot

The Indian health care market is expected to nearly double to US$320 billion by 2028, up from US$180 billion last year

Broker's Calls

DBS optimistic about IHH's growth prospects, maintains 'buy' call

'This is a very attractive level to ride on its medium-term growth trajectory,' says DBS analyst Rachel Tan.
×